Kymera Therapeutics (KYMR) PT Raised to $56 at Stifel
Tweet Send to a Friend
(Updated - November 1, 2024 7:58 AM EDT)
Stifel analyst Bradley Canino raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Bradley Canino raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
